
Best AI Tools for Therapists in 2026
Five AI tools tested for clinical documentation, session notes, treatment planning, and practice management - with verified pricing and honest tradeoffs for solo and group mental health practices.
They summarize our coverage. We write it.
Newsletters like this one rebroadcast our headlines - often without the full review, the source reading, or the analysis underneath. Our weekly briefing sends the work they paraphrase, straight from the desk, before they get to it.
Free, weekly, no spam. One email every Tuesday. Unsubscribe anytime.

Five AI tools tested for clinical documentation, session notes, treatment planning, and practice management - with verified pricing and honest tradeoffs for solo and group mental health practices.

Five leading AI drug discovery platforms compared - AlphaFold 3, IsoDDE, Recursion OS, Insilico Pharma.AI, and NVIDIA BioNeMo. Access, capabilities, pricing, and clinical results.

Five AI clinical documentation platforms compared - Nabla, Suki AI, Corti, Abridge, and Dragon Copilot. Pricing, EHR integrations, and outcomes data for health systems.

OpenAI's first domain-specific reasoning model for biology and drug discovery, launched April 16 2026 as a US-only research preview with a 0.751 BixBench score.

Rankings of AI models on medical QA benchmarks - MedQA USMLE, MedMCQA, PubMedQA, MMLU-Medical, HealthBench, and more. Where a wrong answer has clinical consequences.

OpenAI launched GPT-Rosalind on April 16, a frontier reasoning model for drug discovery that outranked human experts on RNA prediction and competes directly with Google DeepMind's AlphaFold.

Novo Nordisk signs a sweeping AI partnership with OpenAI covering drug discovery, manufacturing, and supply chain - but the governance details are thin.

Three papers: AI safety measures withhold critical clinical guidance from patients, SAT cuts reasoning tokens by 40%, and conformal prediction blocks wrong multi-agent consensus.

Meta's first proprietary frontier model leads on HealthBench Hard and scientific reasoning but trails rivals in coding and agentic tasks - with no public API yet.

Meta Superintelligence Labs releases Muse Spark, its first AI model built from scratch in nine months, landing 4th on the Artificial Analysis Intelligence Index.

Google's MedGemma 1.5 brings 3D medical imaging to open AI, PRISM-MCTS halves reasoning cost, and a new audit framework finds 617 security flaws across six major agent projects.

Utah becomes the first government in the world to approve an AI system to autonomously renew psychiatric medication prescriptions, limiting it to 15 lower-risk drugs under a tightly supervised pilot.